Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1

Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
melanomanon-small-cell-lung-cancerovarian-cancer
sarcoma, melanoma, non-small cell lung cancer, ovarian cancer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 888097
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.